Key points
-
Categorizing COVID-19 mimickers according to chest CT features.
-
Review of clinical and chest CT characteristics of COVID-19 mimickers.
-
Differentiation between COVID-19 and other mimickers.
Background
COVID-19
COVID-19 pneumonia Imaging classification | CT findings | Differential diagnosis |
---|---|---|
CT mimickers of typical COVID-19 Commonly reported imaging features of greater specificity for COVID-19 pneumonia | Typical findings are: 1. Peripheral, bilateral, GGO with or without consolidation or crazy-paving 2. Multifocal GGO of rounded morphology with or without consolidation or crazy-paving 3. Reverse halo sign or other findings of organizing pneumonia | 1. Influenza pneumonia 2. SARS and MERS pneumonia 3. Organizing pneumonia 4. Connective tissue disease (RA) 5. Drug toxicity 6. Acute interstitial pneumonia |
CT mimickers of indeterminate COVID-19 Commonly reported imaging features of greater specificity for COVID-19 pneumonia | Absence of typical features AND presence of: 1. Multifocal, diffuse, perihilar or unilateral GGO with or without consolidation 2. Lacking of specific distribution 3. Non-rounded or non-peripheral GGO | 1. Other causes of viral pneumonia 2. Atypical bacterial infections 3. Pneumocystis infection 4. Pulmonary edema 5. ARDS 6. Acute hypersensitivity pneumonitis, 7. Eosinophilic pneumonia 8. Diffuse alveolar hemorrhage 9. Pulmonary alveolar proteinosis |
Conditions presented by clinical scenarios that mimic COVID-19 but with atypical CT features Uncommonly or not reported CT features | Absence of typical or indeterminate features AND presence of: 1. Isolated lobar or segmental consolidation without GGO 2. Discrete small nodules (centrilobular or “tree in-bud”) 3. Lung cavitation 4. Smooth interlobular septal thickening with pleural effusion | Alternative diagnoses rather than COVID-19 should be considered such as typical bacterial pneumonia, TB or other non-infective processes |
Disease | CT findings | Extra-pulmonary manifestation | Characteristic Laboratory findings | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Location | GGO | Consolidation | Crazy paving | Nodules | Pleural effusion | Other findings | |||||
(1) COVID-19
| Multi-/(less) Unifocal Bilateral Peripheral Posterior or lower zonal | ++++ | ± (more later in the course) | ++ | (R) (either Tree-in-bud or centrilobular) | (R) | (T) Vascular dilation and traction bronchiectasis (S)Architectural distortion and subpleural bands (R) bronchial wall thickening, mucoid impaction or LNs | Abdominal symptoms Acute necrotizing encephalopathy Myocarditis Acute kidney injury | (- -) Lymphocyte count (++) CRP | ||
(2) Viral pneumonia | (a) Influenza A, B and C | Focal Multifocal Diffuse | ++++ | ++ | ++ (Centrilobular) | ++ | Pseudo-cavitation Pneumatocele LNs ± ARDS | Lymphocytosis or lymphopenia | |||
(b) Coronaviridae (SARS/MERS) | Upper and lower resp. infection Multifocal | ++++ | ++ | (R) | (C) Reticulation (R) Cavitation (R) LNs | ||||||
(c) HPIV | Multifocal | ++ | ++++ (patchy) | + (Centrilobular) | Bronchial wall thickening | ||||||
(d) Human adenovirus | Bilateral Multifocal | +++ | Patchy (lobar/segmental) | ++++ (Centrilobular) | ++++ | ||||||
(e) Herpes viruses | Multifocal segmental Diffuse | ++++ | + | (C) Multiple hemorrhagic | ++++ | (C) fungal pneumonia | Gingivostomatitis, pharyngitis and herpes labialis (HSV) | ||||
(f) Human bocavirus | Diffuse Along bronchovascular bundles | ++++ | ++++ (patchy) | ++++ | |||||||
(g) Rhinovirus | Multifocal | ++ | + | (R) | (R) | ||||||
(h) RSV | Airway centric | ± | ++++ | Bronchial wall thickening | |||||||
(j) Measles | Peribronchial | Nodular/reticulo-nodular infiltrates | +++ | Thick interlobular septae (S) Fibrosis (C) Hilar LNs | Lymphadenopathy gastroenteritis, Encephalitis | ||||||
(3) Atypical Bacterial pneumonia (Mycoplasma P. and Chlamydia P.) | Uni-/Bilateral | + | + | + (Centrilobular/peribronchovascular) | (R) | Thick bronchovascular bundle (R) atelectasis Chlamydia P. reticular or linear opacity, airway dilatation and emphysema | Fatigue, Malaise | Mildly ( +) or normal WBC | |||
(4) Pneumocystis jiroveci pneumonia (PJP) | Central with peripheral sparing (++) in upper lobes | ++++ (extensive in non-HIV) | +++ (in non-HIV patients) | ++ (in advanced cases) | + (solitary/multiple) | (C) pulmonary cysts spontaneous pneumothorax (R) cancer-like mass (S) interstitial fibrosis | Tachypnea, tachycardia and cyanosis | (++) LDH (not specific) | |||
(5) Pulmonary edema cardiogenic/non-cardiogenic (ARDS) | Bilateral Perihilar symmetrical (cardiogenic) | ++++ | +++ in ARDS (heterogeneous, peripherally and dependent) | ++ | +++ in cardiogenic edema | (T) Anteroposterior density gradient Pulmonary cysts lately | Cardiomegaly Cyanosis, dyspnea tachypnea in cardiogenic edema | ||||
(6) Hypersensitivity pneumonitis | Acute: normal or diffuse Subacute: mid/upper lung zone Chronic: peribronchovascular (++) at mid/upper lung zones | +++ | Acute: centrilobular ground-glass nodules Subacute: poorly defined CL nodules | Subacute: air trapping (S) Thin walled cysts Chronic: fibrotic changes (septal thickening, traction bronchiectasis, honey combing) | Cyanosis, fatigue, anorexia and weight loss | Non-specific increased ESR and CRP | |||||
(7) Diffuse alveolar hemorrhage
| Diffuse Patchy Lobular Perihilar Gravity-dependent | +++ | +++ | ± | Hemoptysis, anemia, signs of collagen-vascular disease | Thrombocytopenia Coagulopathy | |||||
(8) Pulmonary alveolar proteinosis
| Patchy Subpleural sparing Geographic distribution ++in lower lung | +++ (T) | No | No | No LNs | Weight loss | Elevated LDH | ||||
(9) Eosinophilic P. | Bilateral non-segmental areas Middle and upper lobar predominance | + | ++++ (no subpleural spacing) | + | + | (S) lung reticulations and mediastinal LNs | Alveolar and blood eosinophilia ++IgE ++ ESR Peripheral thrombocytosis | ||||
(10) Interstitial lung disease
|
(A) COP
| Multifocal Subpleural Peribronchial distribution | ++++ | ++++ | + | (R) masses with regional architectural distortion and interlobular septal thickening.
(T) “atoll sign” | Weight loss, generalized bone aches | ||||
(B) DAD/AIP
| Symmetric and bilateral Lower lobe predominance Sparing C/P recesses | ++++ | ++ (in the dependent portions) | + | Later fibrotic phase of DAD Architectural distortion, honeycombing and traction bronchiectasis (similar to UIP) | ||||||
(C) CTD associated P.
| Subpleural and basal predominance | (S) extensive | (S) Segmental | (S) | (C) reticular densities, traction bronchiectasis, honey combing and clustered cysts (S) mosaic perfusion, discrete cysts and air trapping | Systemic manifestation according to type of disease | Detected antinuclear antibodies (ANA) and an antibody to ribonucleoprotein (RNP) |